Vulnerability in Bd Synapsys
CVE-2022-30277
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
EPSS: 0.002 (13.1th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 5.7 (Medium). Vector: CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N.
Affected products
- Bd Synapsys — versions 4.20, 4.30
- Becton Dickinson (Bd) Bd Synapsys™ — versions 4.20
Weakness classification (CWE)
References
- cybersecurity@bd.com (x_refsource_CONFIRM, Vendor Advisory)
Frequently asked questions
- What is CVE-2022-30277?
- CVE-2022-30277 is a medium-severity vulnerability in Bd Synapsys, classified under Insufficient Session Expiration. CVSS score: 5.7/10. Published 2022-06-02.
- How severe is CVE-2022-30277?
- Medium severity. CVSS v3 base score is 5.7 out of 10.